Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-24-000758
Filing Date
2024-12-13
Accepted
2024-12-13 14:55:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12837
2 calcex991.htm EX-99.1 AGREEMENT 4817
  Complete submission text file 0000935836-24-000758.txt   19638
Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91725 | Film No.: 241547990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)